Contact PR

To use this feature, join Babbler easily !

Download this content

Press release

Media information: Sanofi Toujeo medical treatment

Copy link

SWITCHING TO TOUJEO® IN A REAL-WORLD SETTING PRODUCED A SIMILAR NUMBER OF SEVERE LOW BLOOD SUGAR EVENTS AS INSULIN DEGLUDEC

Adults with type 2 diabetes who switched their basal insulin therapy to Toujeo® or insulin degludec, experienced similar numbers of low blood sugar (hypoglycemia) events, according to the findings of two comparative real-world studies. Patients also experienced similar reduction of average blood sugar (HbA1c) with the different insulin treatments. 

  • Health & Medicine
  • Medicine
  • Men's Health
  • Women's Health